Legacy Wealth Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.86M Sell
23,784
-29
-0.1% -$2.34K 0.41% 55
2026
Q1
$2.06M Buy
23,813
+7,234
+44% +$693K 0.5% 38
2025
Q4
$1.59M Sell
16,579
-106
-0.6% -$10.3K 0.39% 58
2025
Q3
$1.59M Sell
16,685
-250
-1% -$23K 0.39% 61
2025
Q2
$1.48M Buy
16,935
+10
+0.1% +$848 0.38% 65
2025
Q1
$1.52M Sell
16,925
-3
-0% -$268 0.42% 65
2024
Q4
$1.35M Sell
16,928
-95
-0.6% -$8.22K 0.37% 65
2024
Q3
$1.53M Sell
17,023
-1,076
-6% -$90.5K 0.41% 67
2024
Q2
$1.42M Buy
18,099
+214
+1% +$17.5K 0.4% 68
2024
Q1
$1.56M Buy
17,885
+313
+2% +$26.7K 0.43% 58
2023
Q4
$1.45M Sell
17,572
-845
-5% -$64.4K 0.48% 58
2023
Q3
$1.44M Sell
18,417
-2,899
-14% -$243K 0.53% 51
2023
Q2
$1.88M Sell
21,316
-4,545
-18% -$391K 0.66% 32
2023
Q1
$2.08M Sell
25,861
-15
-0.1% -$1.22K 0.75% 19
2022
Q4
$2.01M Sell
25,876
-75
-0.3% -$6.08K 0.77% 19
2022
Q3
$2.1M Sell
25,951
-753
-3% -$67.7K 0.92% 9
2022
Q2
$2.4M Buy
26,704
+107
+0.4% +$10.8K 0.97% 13
2022
Q1
$2.95M Buy
26,597
+183
+0.7% +$19.3K 1.05% 11
2021
Q4
$2.73M Buy
26,414
+1,181
+5% +$137K 0.93% 12
2021
Q3
$3.16M Sell
25,233
-113
-0.4% -$14.6K 1.45% 6
2021
Q2
$3.15M Buy
25,346
+119
+0.5% +$14.9K 1.4% 5
2021
Q1
$2.98M Buy
25,227
+8,797
+54% +$1.03M 1.38% 6
2020
Q4
$1.93M Buy
+16,430
New +$1.81M 0.97% 11

Other funds holding MDT

Legacy Wealth Asset Management's MDT Position: Q2 2026 in Review

Legacy Wealth Asset Management reduced its Medtronic (MDT) stake by 0.12% in Q2 2026, selling an estimated $2.34K and leaving 23,784 shares worth $1.86M. The position accounts for 0.41% of the portfolio, ranked #55.

Legacy Wealth Asset Management first reported a position in MDT in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.16M in Q3 2021. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Legacy Wealth Asset Management held 23,784 shares of Medtronic worth $1.86M as of Q2 2026.
  • Legacy Wealth Asset Management sold 29 Medtronic shares in Q2 2026, an estimated $2.34K.
  • Medtronic made up 0.41% of Legacy Wealth Asset Management's portfolio in Q2 2026, its #55 holding.
  • Legacy Wealth Asset Management first reported a position in Medtronic in Q4 2020 and has held it in 23 quarters since.
  • Legacy Wealth Asset Management's Medtronic position peaked at $3.16M in Q3 2021.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Legacy Wealth Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.